Business Wire

China’s 2025 Labor Day Sees Surge in Inbound and Outbound Travel Spending via Alipay and Other Alipay+ Partner Payment Apps

6.5.2025 11:43:00 CEST | Business Wire | Press release

Share

The top destinations for outbound Chinese travelers based on total Alipay spending are Hong Kong SAR, Japan, Macao SAR, South Korea, Thailand, Malaysia, Singapore, France, Canada, and Italy.Inbound travel to China saw a remarkable boost, with both the number of transactions and total spending by travelers using their 13 home e-wallets supported by the Alipay+ solution rising by over 100% year-on-year.

Data from Alipay and other Alipay+ partner payment apps indicates a notable increase in both outbound and inbound tourism spending in China during the 2025 Labor Day holiday (Golden Week).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250505144383/en/

The Myeongdong shopping area in South Korea welcomes travelers to pay with Alipay and other Alipay+ partner payment apps.

Outbound Travel: Chinese tourists explore local experiences through digital platforms in overseas destinations

Through Alipay+, a unified wallet gateway with cross-border payment and digitization services developed by Ant International, users of 36 e-wallets in Asia and Europe—including Chinese travelers—can use their own home payment apps across over 70 markets without the need to exchange currency or carry cash. During China's Labor Day holiday, global Alipay+ merchants have joined Alipay in an exclusive campaign to lure travelers.

The top destinations for Chinese travelers, based on total Alipay spending, are Hong Kong SAR, Japan, Macao SAR, South Korea, Thailand, Malaysia, Singapore, France, Canada, and Italy.

Thanks to Alipay+'s 100 million-strong and diverse global merchant network, Chinese tourists are increasingly seeking more personalized, local experiences. Switzerland recorded the highest average Alipay spending per user, while in South Korea, average spending exceeded USD 100—driven in part by the growing trend of traveling for cosmetic surgery. In addition, the growing desire for immersive local travel experiences is driving increased use of local transportation, with Alipay transactions rising 53% year-over-year. Public transit has become the most frequently used Alipay service among travelers. Taking buses and subways with Alipay is especially popular in Hong Kong SAR and Macao SAR, where travelers are already familiar with using it for daily commutes. Other emerging trends include buying train tickets in Europe and unlocking shared bikes in Japan with Alipay.

Furthermore, Alipay’s real-time tax refund service saw a 33% year-on-year increase in the refund value per transaction, while the number of claims for Alipay’s instant discount offer increased by 46% compared to the New Year’s Day holiday.

Inbound Travel: Visa-free entry, updated tax refund policies, and new payment options attract international travelers

Since September 2023, the Alipay+ solutions have supported 13 leading payment apps1 in Asia to serve their roaming users across Alipay’s extensive merchant network in China.

Thanks to China’s updated tax refund and visa-free policies, more international travelers are heading to the country. During the Labor Day holiday, both the number of transactions and the total spending by travelers using the 13 overseas e-wallets rose by over 100% year-on-year.AlipayHK topped the list for total spending, followed by Malaysia’s Touch ’n Go e-Wallet, Kazakhstan’s Kaspi.kz, Macao SAR’s MPay, and Thailand’s TrueMoney.

With Alipay+, international travelers may also bind their Visa, Mastercard, American Express, JCB, Discover®, Diners Club International®, and UnionPay International credit or debit cards to Alipay for a seamless travel experience in China. This enables smooth payments and access to a wide range of digital services on the Alipay platform, including ride-hailing, hotel bookings, and plane or train ticket purchases.

Alipay Tap!—a contactless payment and customer engagement solution introduced by Alipay in China in June 2024—has also quickly become a preferred payment method among international travelers to China. The solution is essentially a simplified QR-code method that enables users to access services hosted on Alipay simply by tapping a merchant’s terminal or an Alipay Tap! Tag, without needing to open an app, scan a code, or navigate multiple screens. As of April 2025, Alipay Tap! had attracted over 100 million users in China within just 11 months of launch. During the Labor Day holiday, travelers from the 54 countries covered by China’s 240-hour visa-free transit policy spent 50% more via Alipay Tap! compared to the same period in April.

About Alipay+
Ant International's Alipay+ is a unified wallet gateway with cross-border payment and digitization services that help connect global merchants to consumers. Consumers enjoy seamless payments a broad choice of deals and the convenience of digital services using their preferred payment app/e-wallet while travelling abroad. Many small and medium-sized businesses already use Alipay+ digital tools to enhance efficiency and achieve omni-channel growth.

About Alipay
As the world becomes increasingly digital, Alipay has evolved from a trusted e-wallet into an all-in-one digital platform for daily services, connecting more than one billion consumers to over 80 million merchants across China. Alipay offers users a secure, seamless mobile payment experience and integrates over 10,000 services across sectors like travel, healthcare, tourism, and entertainment. With digital tools like Alipay Tap!, mini-programs, lifestyle accounts, Alipay enables merchants, institutions, and independent software vendors (ISVs) to enhance operational efficiency and effectiveness. In addition, Alipay is developing a new AI-driven open platform by integrating AI agents to deliver smarter, more personalized services to its users as well as facilitating the digital transformation of the service sector.

____________________

1 The 13 payment apps include AlipayHK (Hong Kong SAR, China), Kaspi.kz (Kazakhstan), MPay (Macao SAR, China), Touch ’n Go eWallet (Malaysia), Hipay (Mongolia), NayaPay (Pakistan), Changi Pay (Singapore), OCBC Digital (Singapore), Kakao Pay (South Korea), Naver Pay (South Korea), Toss Pay (South Korea), TrueMoney (Thailand), GCash (The Philippines).

View source version on businesswire.com: https://www.businesswire.com/news/home/20250505144383/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release

Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release

News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi

Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo

IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release

Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr

BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release

Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye